Alcami
Wilmington, NCMulti-phase pharmaceutical development and manufacturing for small and large molecules
View CompanyPharma Services
Aging populations, disease prevalence, and heightened consciousness of healthy practices and prevention all contribute to a continual demand for new pharmaceutical and biopharmaceutical products, requiring therapeutics companies to invest heavily in R&D.
However, the increasing cost of research, development, and manufacturing activities is leading to a demand for high quality outsourced pharmaceutical services, and subsequently driving the growth of contract service providers.
With a decades-long track record supporting pharma services companies, Ampersand brings a wealth of experience to the table as a strategic partner. Our collaborative guidance serves as an invaluable asset, positioning portfolio companies for sustained growth and prominence in highly competitive pharma services markets. In addition, Ampersand has helped these companies grow by diversifying service offerings and completing add-on acquisitions.
Key Subsectors
- CDMOs
- CROs
- Contract Packaging
Pharma Services Portfolio
Status
Explore the Full Ampersand Portfolio
Arranta Bio
Watertown, MACDMO focused on the development and commercialization of therapies targeting the human microbiome
Acquired by Recipharm in 2022
View Company
Avista Pharma Solutions
East Rutherford, NJContract development, manufacturing, and testing solutions for generic pharmaceutical products
Acquired by Cambrex in 2018
View Company
BioClinica
Newtown, PAIntegrated clinical research technology solutions for the pharmaceutical, biotechnology, medical device, and contract research industries
Acquired by Cinven in 2016
View Company
Brammer Bio
Cambridge, MAProvider of clinical and commercial supply of viral vectors for in vivo gene and ex vivo cell therapies
Acquired by Thermo Fisher Scientific in 2019
View Company
CRI Lifetree
Mount Laurel, NJEarly-stage patient population studies with a focus on Human Abuse Liability, addiction, pain, psychiatry, neurology, pediatric, and infectious disease services
Acquired by PRA in 2013
View Company
CurTec
Rijen, NetherlandsGlobal manufacturer of high-performance plastic packaging for the pharmaceutical, specialty chemicals, and logistics industries.
View Company
Genezen
Fishers, INContract development and manufacturing for a range of viral vectors to support the development of cell and gene therapies
View Company
iuvo
Rochester, NYA full-service ophthalmology-focused contract research organization (CRO)
View Company
Julius Clinical
Utrecht, NetherlandsCRO network supporting a variety of therapeutic applications, including CNS diseases, cardio-metabolic and renal diseases, and infectious diseases and vaccines
View Company
LakePharma
Dallas, TXProvider of antibody engineering, antibody discovery, molecular engineering, protein chemistry, bioexpression, biofunction, bioprocessing, and bioanalytics
Acquired by Curia in 2021
View Company
MedPharm
Durham, NCGlobal CDMO providing topical and transdermal product design, development, and manufacturing services
View Company
NanoImaging Services
Woburn, MASpecialty CRO providing cryo-EM solutions for the discovery and development of novel therapeutics
View Company
P95
Leuven, BelgiumGlobal provider of clinical and epidemiology research solutions with a focus on vaccines and infectious diseases
View Company
Recipharm
Stockholm, SwedenDrug product services for all common dosage forms from pre-formulation and clinical development through to scale-up and commercial manufacturing
View Company
Vernal Biosciences
Burlington, VTmRNA CDMO dedicated to enhancing industry access to mRNA, LNP-mRNA, and associated services
View Company
Vibalogics
Boxborough, MADeveloper and manufacturer of suspension and adherent cell-based and egg-based viruses
Acquired by Recipharm in 2022
View Company
VIVEbiotech
San Sebastian, SpainLentiviral vector GMP CDMO providing process development, manufacturing and analytical testing
View Company
